These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4007418)

  • 21. Liver transplantation for Wilson's disease.
    Sevmis S; Karakayali H; Aliosmanoglu I; Yilmaz U; Ozcay F; Torgay A; Arslan G; Haberal M
    Transplant Proc; 2008; 40(1):228-30. PubMed ID: 18261593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic copper in primary biliary cirrhosis: biliary excretion and response to penicillamine treatment.
    Salaspuro MP; Pikkarainen P; Sipponen P; Vuori E; Miettinen TA
    Gut; 1981 Nov; 22(11):901-6. PubMed ID: 7308845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.
    Chapman RW; Arborgh BA; Rhodes JM; Summerfield JA; Dick R; Scheuer PJ; Sherlock S
    Gut; 1980 Oct; 21(10):870-7. PubMed ID: 7439807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current concepts. Primary sclerosing cholangitis.
    LaRusso NF; Wiesner RH; Ludwig J; MacCarty RL
    N Engl J Med; 1984 Apr; 310(14):899-903. PubMed ID: 6366557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper.
    Brewer GJ; Hill GM; Dick RD; Nostrant TT; Sams JS; Wells JJ; Prasad AS
    J Lab Clin Med; 1987 May; 109(5):526-31. PubMed ID: 3572199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wilson's disease patients with normal ceruloplasmin levels.
    Yüce A; Koçak N; Ozen H; Gürakan F
    Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copper concentrations in Egyptian infants with cholestasis: A single center study.
    El-Koofy N; Fouad HM; Fahmy ME; Helmy H; Shaker O; El-Karaksy HM; Mohsen N
    Arab J Gastroenterol; 2018 Mar; 19(1):21-25. PubMed ID: 29523470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of variations in the distribution of copper in liver disease.
    Goldfischer S; Popper H; Sternlieb I
    Am J Pathol; 1980 Jun; 99(3):715-30. PubMed ID: 7386600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver copper content in patients with inflammatory bowel disease and associated liver disorders.
    Ritland S; Elgjo K; Johansen O; Steinnes E
    Scand J Gastroenterol; 1979; 14(6):711-5. PubMed ID: 531503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sclerosing cholangitis with neonatal onset.
    Amedee-Manesme O; Bernard O; Brunelle F; Hadchouel M; Polonovski C; Baudon JJ; Beguet P; Alagille D
    J Pediatr; 1987 Aug; 111(2):225-9. PubMed ID: 3612394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis.
    Tjandra K; Sharkey KA; Swain MG
    Hepatology; 2000 Feb; 31(2):280-90. PubMed ID: 10655247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired hepatic copper homeostasis in Long-Evans Cinnamon rats: reduced biliary excretion of copper.
    Suzuki M; Aoki T
    Pediatr Res; 1994 May; 35(5):598-601. PubMed ID: 8065844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
    Trottier J; Białek A; Caron P; Straka RJ; Heathcote J; Milkiewicz P; Barbier O
    Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary excretion of copper, zinc and iron with and without D-penicillamine administration in relation to hepatic copper concentration in dogs.
    Fieten H; Hugen S; van den Ingh TS; Hendriks WH; Vernooij JC; Bode P; Watson AL; Leegwater PA; Rothuizen J
    Vet J; 2013 Aug; 197(2):468-73. PubMed ID: 23583003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal tubular acidosis in primary biliary cirrhosis.
    Parés A; Rimola A; Bruguera M; Mas E; Rodés J
    Gastroenterology; 1981 Apr; 80(4):681-6. PubMed ID: 7202940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resection of hepatic duct bifurcation and transhepatic stenting for sclerosing cholangitis.
    Cameron JL; Pitt HA; Zinner MJ; Herlong HF; Kaufman SL; Boitnott JK; Coleman J
    Ann Surg; 1988 May; 207(5):614-22. PubMed ID: 3377571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevation of ceruloplasmin activity involved in changes of hepatic metal concentration in primary biliary cirrhosis.
    Sogawa K; Yamada T; Suzuki Y; Masaki T; Watanabe S; Uchida Y; Arima K; Nishioka M; Matsumoto K
    Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):367-70. PubMed ID: 7938909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary sclerosing cholangitis.
    Summerfield JA
    Postgrad Med J; 1983; 59 Suppl 4():99-105. PubMed ID: 6359117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis.
    Epstein O; Chapman RW; Lake-Bakaar G; Foo AY; Rosalki SB; Sherlock S
    Gastroenterology; 1982 Dec; 83(6):1177-82. PubMed ID: 7129026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary sclerosing cholangitis.
    Jorge A; Findor J; Esley C; Bruch E
    Z Gastroenterol; 1988 Jun; 26(6):322-30. PubMed ID: 3206917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.